Post-Acute COVID-19
15
5
7
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (15)
Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID
Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program for PASC Program to Improve Functioning of Persons Suffering From Post-COVID-19 Syndrome: A Randomized Controlled Trial
Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome
Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)
Long-Covid-19 Alleviation Through Learning Mindfulness Study
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
Symptom Tracking in Long COVID Patients Using Formula C™ Sublingual Drops
68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19
Co-design of a Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 Using Voice
Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
Genetic Risk Factors for Multi-system Inflammatory Syndrome in Children and Pediatric Post COVID Condition
Post-Covid Condition Cohort: Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors
Safety and Dosage of a Computerized Cognitive Training Program for Cognitive Dysfunction After COVID-19
Personalized Computerized Training Program for Cognitive Dysfunction After COVID-19